title: A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients.
authors.affiliation: Rizk Hospital, Beirut, Lebanon.
authors.forename: A G
authors.initials: AG
authors.lastname: Stephan
authors.forename: A
authors.initials: A
authors.lastname: Barbari
authors.forename: M
authors.initials: M
authors.lastname: Masri
authors.forename: G
authors.initials: G
authors.lastname: Kamel
authors.forename: W
authors.initials: W
authors.lastname: Barakat Khoury
authors.forename: A
authors.initials: A
authors.lastname: Karam
authors.forename: J
authors.initials: J
authors.lastname: Mokhbat
authors.forename: H
authors.initials: H
authors.lastname: Kilany
mesh_terms: D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D013997:Time Factors
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine